Oligodendrocytes and Alzheimer's disease
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Extensive evidence has indicated that the breakdown of myelin is associated with Alzheimer's disease (AD) since the vulnerability of oligodendrocytes under Alzheimer's pathology easily induces the myelin breakdown and the loss of the myelin sheath which might be the initiating step in the changes of the earliest stage of AD prior to appearance of amyloid and tau pathology. Considerable research implicated that beta-amyloid (Aβ)-mediated oligodendrocyte dysfunction and myelin breakdown may be via neuroinflammation, oxidative stress and/or apoptosis. It also seems that the oligodendrocyte dysfunction is triggered by the formation of neurofibrillary tangles (NFTs) through inflammation and oxidative stress as the common pathophysiological base. Impaired repair of oligodendrocyte precursor cells (OPCs) might possibly enhance the disease progress under decreased self-healing ability from aging process and pathological factors including Aβ pathology and/or NFTs. Thus, these results have suggested that targeting oligodendrocytes may be a novel therapeutic intervention for the prevention and treatment of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity
Fünfschilling, U., Supplie, L. M., Mahad, D., Boretius, S., Saab, A. S., Edgar, J., Brinkmann, B. G., Kassmann, C. M., Tzvetanova, I. D., Möbius, W., et al. (2012) · Nature · doi:10.1038/nature11007 · Cited by 1,523 · cited 4×
“Oligodendrocytes arise from OPCs which make up around 5%–8% of the glial cell population in the CNS [103].”
BackgroundInfluentialAβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
Radde, R., Bolmont, T., Kaeser, S. A., Coomaraswamy, J., Lindau, D., Stoltze, L., Calhoun, M. E., Jäggi, F., Wolburg, H., Gengler, S., et al. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400784 · Cited by 986
Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease
Bartzokis, G. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.03.001 · Cited by 968 · cited 1×
“It is even hypothesized that age-related myelin breakdown is homeostatic responses as a developmental model of cognitive decline and AD [28,57,58].”
BackgroundOligodendrocytes: biology and pathology
Bradl, M., & Lassmann, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0601-5 · Cited by 933 · cited 6×
“Oligodendrocytes arise from OPCs which make up around 5%–8% of the glial cell population in the CNS [103].”
BackgroundInfluentialMicroglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease
Cai, Z., Hussain, M. D., & Yan, L.-J. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2013.833510 · Cited by 583 · cited 2×
“The mechanisms and pathways of neuroinflammation triggered by Aβ have been shown in in vivo and in vitro conditions, including an abundance of activated glial cells that results in the release of pro-inflammatory cytokine, inflammatory mediators, free radicals and chemokine [81,83,84].”
BackgroundAlzheimer's disease as homeostatic responses to age-related myelin breakdown
Bartzokis, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.007 · Cited by 546 · cited 4×
“It is even hypothesized that age-related myelin breakdown is homeostatic responses as a developmental model of cognitive decline and AD [28,57,58].”
BackgroundInfluentialChen, C.-H., Zhou, W., Liu, S., Deng, Y., Cai, F., Tone, M., Tone, Y., Tong, Y., & Song, W. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000149 · Cited by 433
Inflammatory process in Alzheimer's Disease
Meraz-Ríos, M. A., Toral-Rios, D., Franco-Bocanegra, D., Villeda-Hernández, J., & Campos-Peña, V. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00059 · Cited by 427
Research works printed but not linked: 84
- 10.2174/092986711795496872 · DOI · Paper page
- Aqdam MJ, 2010, Avicenna J Med Biotechnol, 2, 153
- 10.1111/j.1471-4159.2010.06751.x · DOI
- 10.1016/j.ridd.2013.02.021 · DOI
- de la Torre JC, 2010, J Alzheimers Dis, 20, 861, 10.3233/JAD-2010-091579 · DOI · Paper page
- 10.1016/S0006-8993(03)02658-1 · DOI
- 10.2174/156720509787602843 · DOI · Paper page
- 10.1007/s11064-005-6962-9 · DOI · Paper page
- 10.1089/ars.2011.4277 · DOI · Paper page
- 10.1002/cne.23234 · DOI · Paper page
- 10.1016/j.mrfmmm.2009.08.016 · DOI
- 10.1007/s12640-012-9322-y · DOI · Paper page
- 10.1155/2013/860959 · DOI · Paper page
- 10.1089/ars.2011.4082 · DOI · Paper page
- 10.1159/000213839 · DOI · Paper page
- 10.1523/JNEUROSCI.1496-12.2012 · DOI · Paper page
- 10.4067/S0716-97602001000200017 · DOI · Paper page
- 10.1007/s00005-011-0120-7 · DOI
- 10.1007/s00415-008-1004-6 · DOI · Paper page
- 10.1111/j.1460-9568.2008.06415.x · DOI
- 10.1093/brain/awr014 · DOI · Paper page
- 10.1097/WCO.0b013e32813aee7f · DOI
- 10.1016/j.mehy.2012.12.008 · DOI
- 10.1002/gps.1384 · DOI · Paper page
- 10.1016/S0161-813X(02)00196-1 · DOI
- 10.1371/journal.pone.0038211 · DOI · Paper page
- 10.1111/j.1399-5618.2009.00776.x · DOI
- 10.1016/j.nbd.2011.01.025 · DOI · Paper page
- 10.1212/WNL.56.10.1254 · DOI
- 10.1159/000346682 · DOI
- 10.1016/j.brainres.2012.11.006 · DOI
- 10.1038/aps.2012.141 · DOI
- 10.1186/2040-7378-1-6 · DOI
- 10.1002/1096-9861(20001009)426:1<143::AID-CNE10>3.0.CO;2-8 · DOI · Paper page
- Duyckaerts C, 2003, Rev Neurol (Paris), 159, 3S11
- 10.1016/j.neulet.2009.05.051 · DOI
- 10.1002/glia.21131 · DOI · Paper page
- 10.1016/j.bandc.2012.09.006 · DOI
- 10.1080/13803395.2011.595397 · DOI · Paper page
- Bartzokis G, 2004, J Alzheimers Dis, 6, S53
- 10.1016/j.neurobiolaging.2008.08.015 · DOI · Paper page
- Games D, 1995, Neuron, 373, 523
- 10.1016/j.jalz.2007.01.019 · DOI · Paper page
- 10.1097/00001756-200308060-00005 · DOI · Paper page
- 10.1016/j.neurobiolaging.2010.05.007 · DOI · Paper page
- 10.1111/j.1365-2990.1994.tb00958.x · doi:10.1111/j.1365-2990.1994.tb00958.x
- Glezer I, 2006, FASEB J, 20, 750, 10.1096/fj.05-5234fje · DOI · Paper page
- 10.1523/JNEUROSCI.3467-12.2013 · DOI · Paper page
- 10.1186/1471-2202-7-S1-S2 · DOI
- 10.1016/j.nbd.2010.04.011 · DOI · Paper page
- 10.2217/bmm.09.89 · DOI · Paper page
- 10.2741/s149 · DOI · Paper page
- 10.1038/sj.cdd.4401818 · DOI · Paper page
- 10.1358/mf.2008.30.1.1090962 · DOI · Paper page
- 10.1016/j.jsb.2005.11.001 · DOI · Paper page
- 10.1523/JNEUROSCI.3517-11.2012 · DOI · Paper page
- 10.1016/j.neulet.2011.01.022 · DOI
- 10.2174/156720512802455386 · DOI · Paper page
- 10.1007/s00216-013-6825-1 · DOI
- 10.1016/j.stem.2013.01.019 · DOI · Paper page
- 10.1371/journal.pone.0077182 · DOI
- 10.1007/s11064-008-9701-1 · DOI
- 10.1111/j.1440-1819.1997.tb02588.x · DOI
- 10.1006/exnr.1994.1108 · DOI
- 10.1159/000212515 · DOI
- 10.1007/BF00687256 · DOI
- 10.1111/j.1750-3639.2009.00286.x · DOI
- 10.1016/S0197-4580(01)00281-0 · DOI
- 10.1159/000106634 · doi:10.1159/000106634
- 10.1002/ana.410220206 · DOI · Paper page
- 10.2174/1567205052772713 · DOI · Paper page
- 10.1046/j.0953-816x.2001.01604.x · DOI · Paper page
- Nishimura M, 1995, Am J Pathol, 146, 1052
- Heckl S, 2004, Histol Histopathol, 19, 651
- Cai Z, 2013, J Biochem Pharmacol Res, 1, 84
- 10.1159/000335380 · DOI
- 10.1002/glia.21082 · DOI
- 10.1016/S0166-2236(00)01691-X · DOI · Paper page
- 10.1046/j.1471-4159.1994.62031039.x · DOI · Paper page
- 10.1111/j.1600-0404.1989.tb03886.x · DOI · Paper page
- Yokoi S, 1982, No To Shinkei, 34, 1197
- 10.1111/j.1471-4159.1992.tb10994.x · DOI · Paper page
- 10.1046/j.0305-1846.2003.00510.x · DOI · Paper page
- 10.1007/s00401-009-0635-8 · DOI · Paper page
Cited by
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
“Oligodendrocytes and oligodendrocyte precursor cells (OPCs) dysfunction, as well as myelin breakdown have been suggested to also play an important role in the pathogenesis and progression of AD, although the exact mechanisms remain unclear [164,171].”
BackgroundBeyond the neuron–cellular interactions early in Alzheimer disease pathogenesis
Henstridge, C. M., Hyman, B. T., & Spires-Jones, T. L. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0113-1 · Cited by 348
Huang, F., Pariante, C. M., & Borsini, A. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.09.021 · Cited by 117
Integrative genomics approach identifies conserved transcriptomic networks in Alzheimer’s disease
Morabito, S., Miyoshi, E., Michael, N., & Swarup, V. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa182 · Cited by 74
Myelin in Alzheimer’s disease: culprit or bystander?
Maitre, M., Jeltsch-David, H., Okechukwu, N. G., Klein, C., Patte-Mensah, C., & Mensah-Nyagan, A.-G. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01554-5 · Cited by 66
Metadata
- Authors
- Cai, Z., & Xiao, M.
- Venue
- International Journal of Neuroscience
- Publisher
- Informa UK Limited
- Published
- 2015-07-14
- Volume
- 126
- Issue
- 2
- Pages
- 97-104
- ISSN
- 0020-7454 (ISSN-L)
- 1543-5245
- OpenAlex
- W1871951421
- Cited by
- 133
- References
- 26
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oligodendrocytes and Alzheimer's disease. https://app.cochat.ai/papers/10.3109/00207454.2015.1025778
- The paper
- Cai, Z., & Xiao, M. (2016). Oligodendrocytes and Alzheimer's disease. International Journal of Neuroscience. https://doi.org/10.3109/00207454.2015.1025778
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.